Introduced to the pharmaceutical industry decades ago, lipid-based drug delivery systems are the most well-studied and widely utilized technology among all available bioavailability enhancement technologies. Lipid-based drug delivery systems have delivered more than 60 unique drug molecules to market – and counting. With today’s increasingly complex new molecules emerging from R&D, optimizing bioavailability for early phase molecules is critical to their success. Not only do lipid-based drug delivery systems provide a reliable solution for poorly soluble molecules, they also allow for efficient and scalable dose formulation solutions which can accelerate progress to clinic and beyond, especially for orphan and breakthrough therapies.
Watch this webinar to learn more about:
- The importance of and recent developments in lipid-based drug delivery systems
- Novel lipid excipients, models, and screening tools for early phase development of lipid-based drug delivery systems
- Using mechanistic studies and modeling to predict the impact of lipids on oral absorption